📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia. (2022)

First Author: Maciocia PM

Attributed to: Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021013648

PubMed Identifier: 35507686

Publication URI: http://europepmc.org/abstract/MED/35507686

Type: Journal Article/Review

Volume: 140

Parent Publication: Blood

Issue: 1

ISSN: 0006-4971